Financials
| Half-year Report | Sep. 13, 2024 |
| Annual Financial Report | Apr. 30, 2024 |
| Interim Financial Results | Sep. 27, 2023 |
| Final Results | Apr. 27, 2023 |
| Interim Results | Sep. 30, 2022 |
| Final Results | Jun. 29, 2022 |
| Operational Update | Jun. 20, 2022 |
Proxies
| Result of AGM | Jun. 28, 2024 |
| Notice of AGM | Jun. 04, 2024 |
| Result of AGM | Jul. 27, 2023 |
| AGM Notice | Jul. 04, 2023 |
| Result of AGM | Jul. 28, 2022 |
| Notice of AGM | Jul. 04, 2022 |
Ownership Update
| Holding(s) in Company | Aug. 13, 2024 |
| Holding(s) in Company | Aug. 08, 2024 |
| Holding(s) in Company | Jul. 23, 2024 |
| Holding(s) in Company | Jul. 17, 2024 |
| Holding(s) in Company | Jul. 12, 2024 |
| Holding(s) in Company | Jul. 12, 2024 |
| Holding(s) in Company | Jul. 11, 2024 |
Announcements
| Change of Name to Solvonis Therapeutics plc | Jan. 14, 2025 |
| Result of General Meeting and change of name | Jan. 06, 2025 |
| Initial Results University of Nottingham | Dec. 11, 2024 |
| Research Agreement | Oct. 15, 2024 |
| Research and development update | Oct. 04, 2024 |
| Directorate Change and grant of options | Sep. 26, 2024 |
| Commercial Collaboration Progress Update | Aug. 28, 2024 |
Prospectuses
| Graft Polymer (UK) Plc - Single prospectus | Dec. 21, 2021 |